sivextro
merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
fortum stungulyfs-/innrennslisstofn, lausn 2 g
sandoz a/s - ceftazidimum inn - stungulyfs-/innrennslisstofn, lausn - 2 g
fortum stungulyfsstofn, lausn 1 g
sandoz a/s - ceftazidimum inn - stungulyfsstofn, lausn - 1 g
ceftazidima normon (ceftazidime) stungulyfsstofn og leysir, lausn 1 g
laboratorios normon s.a. - ceftazidimum inn - stungulyfsstofn og leysir, lausn - 1 g
ceftazidima normon (ceftazidime) innrennslisstofn, lausn 2 g
laboratorios normon s.a. - ceftazidimum inn - innrennslisstofn, lausn - 2 g
ringer-acetat baxter viaflo innrennslislyf, lausn
baxter medical ab* - natrii chloridum; kalii chloridum; calcium chloride; magnesii chloridum; natrii acetas - innrennslislyf, lausn
azitromicina normon filmuhúðuð tafla 500 mg
laboratorios normon s.a. - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
cinveron stungulyf, lausn 2 mg/ml
williams & halls ehf - ondansetronum hýdróklóríð - stungulyf, lausn - 2 mg/ml
zitromax filmuhúðuð tafla 500 mg
pfizer aps - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
zitromax mixtúruduft, dreifa 40 mg/ml
pfizer aps - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml